Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
10/31/1991 | WO1991016066A1 Composition and treatment with biologically active peptides and toxic cations |
10/31/1991 | WO1991009118A3 Activatable fibrinolytic and anti-thrombotic proteins |
10/31/1991 | CA2081308A1 Method for increasing blood-brain barrier permeability |
10/30/1991 | EP0454126A1 Polyaminoacids as builders for detergent formulations |
10/30/1991 | EP0438519A4 Therapeutic peptides |
10/29/1991 | US5061693 Fibrinogen receptor antagonists |
10/29/1991 | US5061623 Peptides comprising an immunogenic site of poliovirus and dnas containing nucleotide sequences coding for these peptides |
10/29/1991 | CA1291592C Peptide antagonists of neurokinin b |
10/24/1991 | WO1991016345A1 Cyclic peptides and their use |
10/24/1991 | CA2081312A1 Cyclic peptides and their use |
10/24/1991 | CA2040510A1 Composition and treatment with biologically active peptides and toxic cations |
10/23/1991 | EP0452514A1 Peptide and process for preparing cyclic peptide |
10/23/1991 | EP0452447A1 Reduced irreversible bombesin antagonists |
10/23/1991 | EP0170697B1 Toxin conjugates |
10/23/1991 | CN1055540A 杂种降钙素 Hybrid calcitonin |
10/22/1991 | US5059653 To improve proteolytic stability, reacting side chain amino with an aldehyde or ketone using sodium cyanoborohydride |
10/22/1991 | US5059588 Methods and compositions for healing bone using gly his lys: copper |
10/22/1991 | US5059425 For wound healing, implant acceptance; promote cellular attachment to culture substrate; inhibit metastatis of tumor cells |
10/18/1991 | WO1991016336A1 Fluorogenic peptides and their use in the determination of enzymatic activities |
10/18/1991 | CA2080694A1 Fluorogenic peptides and their use in the determination of enzymatic activities |
10/17/1991 | WO1991015589A1 Improved process of purifying recombinant proteins and compounds useful in such process |
10/17/1991 | WO1991015511A1 Hybrid calcitonin |
10/17/1991 | WO1991015508A1 Human splenopentine derivatives and process for producing them |
10/17/1991 | WO1991015225A1 Multiple sclerosis t-cell receptor |
10/17/1991 | WO1991015224A1 Inhibition of disease associated with immunodeficiency virus infection |
10/17/1991 | CA2080233A1 Hybrid calcitonin |
10/16/1991 | EP0451957A2 Cyclohexapeptide compound |
10/16/1991 | EP0451763A2 Peptide derivatives with amphiphatic properties, intermediates thereof and liposomes and films comprising said derivatives |
10/15/1991 | US5057411 For identifying specific viruses |
10/10/1991 | DE4011207A1 Humane splenopentinderivate und verfahren zu deren herstellung Human splenopentinderivate and processes for their preparation |
10/09/1991 | EP0450461A2 LHRH Analogs |
10/09/1991 | EP0449973A1 Polypeptide-polymer conjugates active in wound healing. |
10/09/1991 | EP0449915A1 New tnf peptides |
10/09/1991 | EP0449871A1 Method for predicting biological activity of antibiotics, and novel non beta-lactam antibacterial agents derived therefrom |
10/08/1991 | US5055448 Diuretics |
10/08/1991 | US5055396 Diagnostic methods and systems for quantifying apo ai |
10/08/1991 | US5055391 Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2) |
10/07/1991 | WO1991015515A1 Method and composition for treating thrombosis |
10/07/1991 | CA2079606A1 Method and composition for treating thrombosis |
10/07/1991 | CA2039908A1 Lhrh analogues |
10/04/1991 | WO1991015512A2 Hiv envelope polypeptides |
10/04/1991 | CA2078545A1 Hiv envelope polypeptides |
10/04/1991 | CA2022523A1 Chemically modified cd4 peptide fragments having anti-retroviral properties |
10/02/1991 | EP0449079A2 Hydantoin derivative |
10/02/1991 | EP0448687A1 Therapeutic decapeptides |
10/02/1991 | EP0217804B1 Analogs of substances p |
10/02/1991 | CN1054900A Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
10/01/1991 | CA1290097C Peptide enzyme inhibitors |
09/25/1991 | EP0448513A2 Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof |
09/25/1991 | EP0448356A2 Lipopeptide compounds |
09/25/1991 | EP0448355A2 Antibiotic agents |
09/25/1991 | EP0448354A2 Lipopeptide derivatives |
09/25/1991 | EP0448353A2 Lipopeptide compounds |
09/25/1991 | EP0448343A2 Lipopeptide derivatives |
09/25/1991 | EP0448301A2 Antibiotic agents |
09/25/1991 | EP0448126A1 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
09/25/1991 | EP0448099A2 Novel peptides |
09/25/1991 | EP0447476A1 New tnf peptides |
09/25/1991 | EP0447474A1 New tnf peptides |
09/25/1991 | EP0447472A1 New tnf peptides |
09/25/1991 | EP0447465A1 New tnf peptides |
09/25/1991 | EP0447435A1 Novel tnf peptides |
09/25/1991 | EP0447432A1 New tnf peptides |
09/25/1991 | EP0447431A1 New tnf peptides |
09/25/1991 | EP0447430A1 New tnf peptides |
09/25/1991 | EP0447429A1 New tnf peptides |
09/25/1991 | EP0378671A4 Insulinomimetic and insulin receptor binding site peptides |
09/25/1991 | CN1054773A Hemoregulatory peptides |
09/25/1991 | CN1054772A Synthetic polypeptides |
09/24/1991 | US5051526 Reagents for solid phase synthesis of polypeptides |
09/24/1991 | US5051496 Polypeptides encoded by DNA fragments for detection of AIDS |
09/24/1991 | US5051403 Method of treating ischemia-related neuronal damage |
09/24/1991 | US5051401 Inhibition of mineral deposition by phosphorylated and related polyanionic peptides |
09/22/1991 | CA2038569A1 Process for production of peptidylglycine ó-hydroxylating monooxygenase and use thereof |
09/20/1991 | CA2038547A1 Lipopeptide compounds |
09/20/1991 | CA2038532A1 Antibiotic agents |
09/20/1991 | CA2038528A1 Lipopeptide derivatives |
09/20/1991 | CA2038525A1 Lipopeptide compounds |
09/20/1991 | CA2038497A1 Lipopeptide derivatives |
09/20/1991 | CA2038495A1 Antibiotic agents |
09/19/1991 | WO1991013985A1 Leukaemia inhibitory factor |
09/19/1991 | WO1991013908A1 Neutrophil stimulating peptides |
09/18/1991 | EP0447186A1 N-acylated cyclohexapeptide compounds |
09/18/1991 | EP0446797A2 Synthetic peptides containing factor VIIa sequences and their use |
09/18/1991 | EP0446706A2 Peptides with tachykinin-agonistic or -antagonistic activity |
09/18/1991 | EP0193608B1 Gif-2 and its preparation |
09/17/1991 | US5049655 Melanin-concentrating hormones |
09/17/1991 | US5049546 Fungicides |
09/17/1991 | US5049506 Proline-containing decapeptides as substrates for factor XIII |
09/16/1991 | WO1991013909A1 Synthetic polypeptides |
09/16/1991 | CA2078220A1 Synthetic polypeptides |
09/14/1991 | CA2037990A1 Amino acid derivatives |
09/13/1991 | CA2037957A1 N-acylated cyclohexapeptide compounds |
09/11/1991 | EP0445606A1 Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides |
09/11/1991 | EP0445423A2 Hepatitis C assay |
09/11/1991 | EP0441871A4 A sheet feeding apparatus |
09/10/1991 | WO1991013925A1 Method for polymerization of epoxide compounds |
09/10/1991 | WO1991013910A1 Peptides stimulating cytotoxic t cells immune to hiv rt |
09/10/1991 | US5047396 Intravenous pharmaceutical composition and process for preparing the same |
09/06/1991 | WO1991013904A1 Chymotrypsin-like proteases and their inhibitors |